The Substance Abuse Trend and Response Task Force seats three committees:
Substance-Exposed Newborns Steering Committee
The Substance-Exposed Newborns Steering Committee addresses a variety of issues regarding the screening for and identification of drug-exposed infants and the connection to substance abuse treatment services for pregnant and post-partum women.
- Kathryn Wells, MD, Medical Director, Denver Family Crisis Center
- Jade Woodard, Executive Director of Colorado Alliance for Drug Endangered Children
Prescription Drug Abuse Prevention Committee
The Colorado Consortium for Prescription Drug Abuse Prevention serves as the Prescription Drug Abuse Prevention Committee of the Task Force and consists of seven work groups that are responsible for implementing the goals and strategies of the Governor’s Colorado Plan to Reduce Prescription Drug Abuse (2013).
Chair: Robert Valuck, Ph.D., Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Clinical Pharmacy, University of Colorado
The Colorado State Epidemiological Outcomes Workgroup serves as the Data Committee of the Task Force. The SEOW compiles data from numerous sources on various drugs of abuse – in particular, alcohol, marijuana, opioids, cocaine, marijuana, and synthetic drugs – to monitor and report on drug trends.
Chair: Sharon Liu, Office of Behavioral Health, Colorado Department of Human Services
SBIRT Advisory Council
The SBIRT Advisory Council identifies best practice approaches and barriers to implementing Screening, Brief Intervention, and Referral to Treatment as a standard of care throughout Colorado’s health and mental health care systems.
- Bethany Pace-Danley, BSW, MA, Program Manager, SBIRT in Colorado, Peer Assistance Services, Inc.
- Kacy Crawford, Alcohol Epidemiologist, Violence and Injury Prevention-Mental Health Branch, Colorado Department of Public Health and Environment.